Alan Cullen

Title: Alan Cullen - Innovator in Pharmaceutical Compositions

Introduction

Alan Cullen is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for oral administration. With a total of two patents to his name, Cullen's work focuses on enhancing the bioavailability of therapeutic agents.

Latest Patents

Cullen's latest patents include innovative pharmaceutical compositions of selective factor Xa inhibitors for oral administration. This invention provides compositions that comprise a therapeutically effective amount of a selective factor Xa inhibitor or a pharmaceutically acceptable salt thereof, along with an enhancer. The enhancer is a medium chain fatty acid or its derivatives, which helps achieve reproducible bioavailability after oral administration. Another significant patent involves pharmaceutical compositions of iron for oral administration. This invention relates to the use of iron compounds with medium chain fatty acid salts to treat iron deficiency and related disorders.

Career Highlights

Alan Cullen is associated with Merrion Research III Limited, where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in developing effective treatments that address critical health issues.

Collaborations

Cullen collaborates with esteemed colleagues such as Thomas W Leonard and David C Coughlan, contributing to a dynamic research environment that fosters innovation.

Conclusion

Alan Cullen's contributions to pharmaceutical compositions demonstrate his commitment to improving healthcare through innovative solutions. His patents reflect a deep understanding of the complexities involved in drug formulation and administration.